Faster, Please! β’ 1553 implied HN points β’ 30 Oct 24
- GLP-1 drugs like Ozempic and Wegovy could change the way we treat obesity and have a huge positive impact on health. They work by helping individuals lose weight and may also lower the risk of serious diseases like diabetes and Alzheimer's.
- These medications could boost the US economy significantly. Estimates suggest that by improving health and productivity, they might help increase the GDP by about 0.5 to 1 percent in rich countries.
- The overall benefits of health innovations, including GLP-1 drugs, aren't fully captured in traditional economic measures. They can lead to a better quality of life and longer life expectancy, which is valuable beyond just the numbers.